{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:18:35Z","timestamp":1793056715608,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejps.2024.106995","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T19:09:15Z","timestamp":1734721755000},"page":"106995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Intradermal versus subcutaneous immunization: Effects of administration route using a lipid-PLGA hybrid nanoparticle tuberculosis vaccine"],"prefix":"10.1016","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3859-314X","authenticated-orcid":false,"given":"M.M.","family":"Szachniewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.F.","family":"van den Eeden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.E.","family":"van Meijgaarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.M.C.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"van Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Geluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Bouwstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.H.M.","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ejps.2024.106995_bib0001","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"2","author":"Aagaard","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2024.106995_bib0002","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults","volume":"181","author":"Abel","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejps.2024.106995_bib0003","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3390\/pharmaceutics14122728","article-title":"PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases","volume":"14","author":"Alsaab","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2024.106995_bib0004","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.smim.2018.05.003","article-title":"Antibody glycosylation in inflammation, disease and vaccination","volume":"39","author":"Alter","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0005","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.4049\/jimmunol.1003189","article-title":"A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis","volume":"186","author":"Balu","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0006","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230859","article-title":"A half-century of research on tuberculosis: Successes and challenges","volume":"220","author":"Bloom","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejps.2024.106995_bib0007","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1172\/JCI32933","article-title":"New TB vaccines: is there a requirement for CD8+ T cells?","volume":"117","author":"Boom","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2024.106995_bib0008","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.164.12.6417","article-title":"Infection of B Cell-Deficient Mice with CDC 1551, a Clinical Isolate of Mycobacterium tuberculosis: Delay in Dissemination and Development of Lung Pathology","volume":"164","author":"Bosio","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0009","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing Tuberculosis with Bacillus Calmette-Gu\u00e9rin Vaccine: A Meta-Analysis of the Literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2024.106995_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/745483","article-title":"Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis","author":"Cavalcanti","year":"2012","journal-title":"Pulm. Med."},{"key":"10.1016\/j.ejps.2024.106995_bib0011","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1586\/erv.11.17","article-title":"Cationic liposomes as vaccine adjuvants","volume":"10","author":"Christensen","year":"2011","journal-title":"Expert. Rev. Vaccines."},{"key":"10.1016\/j.ejps.2024.106995_bib0012","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.4049\/jimmunol.1201593","article-title":"An Unbiased Genome-Wide Mycobacterium tuberculosis Gene Expression Approach To Discover Antigens Targeted by Human T Cells Expressed during Pulmonary Infection","volume":"190","author":"Commandeur","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0013","first-page":"1","article-title":"Age and sex influence antibody profiles associated with tuberculosis progression","volume":"2024","author":"Davies","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejps.2024.106995_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102307","article-title":"Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant","volume":"139","author":"Duong","year":"2023","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejps.2024.106995_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.35693","article-title":"Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis","volume":"4","author":"Egunsola","year":"2021","journal-title":"JAMa Netw. Open."},{"key":"10.1016\/j.ejps.2024.106995_bib0016","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2036.2006.03002.x","article-title":"Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2024.106995_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/prep.1999.1162","article-title":"Purification of His-Tagged Proteins by Immobilized Chelate Affinity Chromatography: The Benefits from the Use of Organic Solvent","volume":"18","author":"Franken","year":"2000","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejps.2024.106995_bib0018","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1016\/j.vaccine.2012.10.045","article-title":"A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice","volume":"30","author":"Geluk","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ejps.2024.106995_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2020.108805","article-title":"Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine","volume":"193","author":"Ghitman","year":"2020","journal-title":"Mater. Des."},{"key":"10.1016\/j.ejps.2024.106995_bib0020","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.4049\/jimmunol.1500792","article-title":"B Cell\u2013Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus","volume":"195","author":"Giles","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0021","volume":"12","author":"Grace","year":"2021","journal-title":"Antibody Subclass and Glycosylation Shift Following Effective TB Treatment. Front Immunol"},{"key":"10.1016\/j.ejps.2024.106995_bib0022","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.micinf.2005.12.004","article-title":"Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice","volume":"8","author":"Guirado","year":"2006","journal-title":"Microbes. Infect."},{"key":"10.1016\/j.ejps.2024.106995_bib0023","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","article-title":"Lipid\u2013polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review","volume":"85","author":"Hadinoto","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"17","key":"10.1016\/j.ejps.2024.106995_bib0024","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nm.2299","article-title":"Dominant TNF-\u03b1+ Mycobacterium tuberculosis\u2013specific CD4+ T cell responses discriminate between latent infection and active disease","volume":"3","author":"Harari","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2024.106995_bib0025","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/CVI.00368-09","article-title":"Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with mycobacterium tuberculosis","volume":"17","author":"Henao-Tamayo","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0026","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0962-8479(97)90006-X","article-title":"Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice","volume":"78","author":"Johnson","year":"1997","journal-title":"Tuberc Lung Dis"},{"key":"10.1016\/j.ejps.2024.106995_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005687","article-title":"Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment","volume":"12","author":"Joosten","year":"2016","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.ejps.2024.106995_bib0028","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2017.08.040","article-title":"Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design","volume":"112","author":"Karbalaei Zadeh Babaki","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejps.2024.106995_bib0029","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev-immunol-051116-052215","article-title":"Antigen-Presenting Cells in the Skin","volume":"35","author":"Kashem","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0030","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.micpath.2018.10.023","article-title":"A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity","volume":"125","author":"Khademi","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejps.2024.106995_bib0031","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/apm.12851","article-title":"Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB\/c mice using PLGA and DOTAP adjuvant","volume":"126","author":"Khademi","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.ejps.2024.106995_bib0032","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.4049\/jimmunol.1500981","article-title":"Role of B Cells in Mucosal Vaccine\u2013Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis","volume":"195","author":"Khera","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0033","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1128\/IAI.73.11.7759-7764.2005","article-title":"Memory T Lymphocytes Generated by Mycobacterium bovis BCG Vaccination Reside within a CD4 CD44lo CD62 Ligandhi Population","volume":"73","author":"Kipnis","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejps.2024.106995_bib0034","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejpb.2018.11.013","article-title":"Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment","volume":"134","author":"Leone","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2024.106995_bib0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4161\/hv.34299","article-title":"Tailored immunity by skin antigen-presenting cells","volume":"11","author":"Levin","year":"2015","journal-title":"Hum. Vaccin. ImmunOther"},{"key":"10.1016\/j.ejps.2024.106995_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01262","article-title":"Polyfunctional CD4+ T cells as targets for tuberculosis vaccination","volume":"8","author":"Lewinsohn","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0037","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.ejps.2024.106995_bib0038","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molimm.2014.06.007","article-title":"A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice","volume":"62","author":"Li","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0039","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1089\/aid.2012.0028","article-title":"CD4 T Cell Depletion Exacerbates Acute Mycobacterium tuberculosis While Reactivation of Latent Infection Is Dependent on Severity of Tissue Depletion in Cynomolgus Macaques","volume":"28","author":"Lin","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.ejps.2024.106995_bib0040","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells","volume":"182","author":"Lindenstr\u00f8m","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0041","doi-asserted-by":"crossref","first-page":"11969","DOI":"10.1021\/acsami.6b01135","article-title":"Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses","volume":"8","author":"Liu","year":"2016","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.ejps.2024.106995_bib0042","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jconrel.2016.01.050","article-title":"Immune responses to vaccines delivered by encapsulation into and\/or adsorption onto cationic lipid-PLGA hybrid nanoparticles","volume":"225","author":"Liu","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2024.106995_bib0043","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A Functional Role for Antibodies in Tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2024.106995_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109696","article-title":"CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection","volume":"36","author":"Lu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejps.2024.106995_bib0045","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.4049\/jimmunol.178.11.7222","article-title":"B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis","volume":"178","author":"Maglione","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0046","doi-asserted-by":"crossref","first-page":"e31472","DOI":"10.1371\/journal.pone.0031472","article-title":"Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine","volume":"7","author":"Moon","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejps.2024.106995_bib0047","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern Subunit Vaccines: Development, Components, and Research Opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem."},{"key":"10.1016\/j.ejps.2024.106995_bib0048","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/srt.12576","article-title":"Enhanced immunity in intradermal vaccination by novel hollow microneedles","volume":"24","author":"Ogai","year":"2018","journal-title":"Skin. Res. Technol."},{"key":"10.1016\/j.ejps.2024.106995_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.ejps.2024.106995_bib0050","doi-asserted-by":"crossref","unstructured":"Ottenhoff, T.H.M., Lewinsohn, D.A., Lewinsohn, D.M., 2008. Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis: Antigen Specificity, Function, Implications and Applications. Handbook of Tuberculosis 119\u2013155. https:\/\/doi.org\/10.1002\/9783527611614.CH23.","DOI":"10.1002\/9783527611614.ch23"},{"key":"10.1016\/j.ejps.2024.106995_bib0051","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drudis.2014.09.018","article-title":"Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives","volume":"20","author":"Pandita","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2024.106995_bib0052","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/IAI.00083-16","article-title":"Effects of B cell depletion on early Mycobacterium tuberculosis infection in cynomolgus macaques","volume":"84","author":"Phuah","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejps.2024.106995_bib0053","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajpath.2012.05.009","article-title":"Activated B Cells in the Granulomas of Nonhuman Primates Infected with Mycobacterium tuberculosis","volume":"181","author":"Phuah","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2024.106995_bib0054","doi-asserted-by":"crossref","first-page":"83298","DOI":"10.3389\/fimmu.2014.00180","article-title":"Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis","volume":"5","author":"Prezzemolo","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0055","unstructured":"R Core Team, 2023. R: A language and environment for statistical computing."},{"key":"10.1016\/j.ejps.2024.106995_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640168","article-title":"B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis","volume":"12","author":"Rijnink","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0057","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2017.12.003","article-title":"A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522","volume":"271","author":"Rose","year":"2018","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2024.106995_bib0058","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1128\/IAI.73.9.6101-6109.2005","article-title":"Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice","volume":"73","author":"Roy","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejps.2024.106995_bib0059","unstructured":"RStudio Team, 2023. RStudio: Integrated Development Environment for R."},{"key":"10.1016\/j.ejps.2024.106995_bib0060","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/IJN.S40579","article-title":"Concepts and practices used to develop functional PLGA-based nanoparticulate systems","volume":"8","author":"Sah","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2024.106995_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101868","article-title":"Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis","volume":"37","author":"Schnyder","year":"2020","journal-title":"Travel. Med. Infect. Dis."},{"key":"10.1016\/j.ejps.2024.106995_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2021.102007","article-title":"Comparison of equivalent fractional vaccine doses delivered by intradermal and intramuscular or subcutaneous routes: A systematic review","volume":"41","author":"Schnyder","year":"2021","journal-title":"Travel. Med. Infect. Dis."},{"key":"10.1016\/j.ejps.2024.106995_bib0063","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1473-3099(19)30625-5","article-title":"The status of tuberculosis vaccine development","volume":"20","author":"Schrager","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejps.2024.106995_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124842","article-title":"Evaluation of PLGA, lipid-PLGA hybrid nanoparticles, and cationic pH-sensitive liposomes as tuberculosis vaccine delivery systems in a Mycobacterium tuberculosis challenge mouse model \u2013 A comparison","volume":"666","author":"Szachniewicz","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106995_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106730","article-title":"Intrinsic immunogenicity of liposomes for tuberculosis vaccines: Effect of cationic lipid and cholesterol","volume":"195","author":"Szachniewicz","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2024.106995_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114437","article-title":"Cationic pH-sensitive liposome-based subunit tuberculosis vaccine induces protection in mice challenged with Mycobacterium tuberculosis","volume":"203","author":"Szachniewicz","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2024.106995_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113782","article-title":"Cationic pH-sensitive liposomes as tuberculosis subunit vaccine delivery systems: Effect of liposome composition on cellular innate immune responses","volume":"145","author":"Szachniewicz","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejps.2024.106995_bib0067","doi-asserted-by":"crossref","first-page":"e61681","DOI":"10.1371\/journal.pone.0061681","article-title":"Differential and Site Specific Impact of B Cells in the Protective Immune Response to Mycobacterium tuberculosis in the Mouse","volume":"8","author":"Torrado","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejps.2024.106995_bib0068","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2024.106995_bib0069","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1462-5822.2005.00612.x","article-title":"Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension","volume":"8","author":"Tsai","year":"2006","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ejps.2024.106995_bib0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0531-5565(00)00257-6","article-title":"The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4","volume":"36","author":"Turner","year":"2001","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ejps.2024.106995_bib0071","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4","article-title":"Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells","volume":"30","author":"Van Pinxteren","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0072","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-2249.1996.d01-845.x","article-title":"Increase of tuberculous infection in the organs of B cell-deficient mice","volume":"106","author":"Vordermeier","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0073","series-title":"Global Tuberculosis Report 2023","year":"2023"},{"key":"10.1016\/j.ejps.2024.106995_bib0074","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0304-3959(99)00231-6","article-title":"Intramuscular and intradermal injection of capsaicin: a comparison of local and referred pain","volume":"84","author":"Witting","year":"2000","journal-title":"Pain."},{"key":"10.1016\/j.ejps.2024.106995_bib0075","doi-asserted-by":"crossref","first-page":"8595","DOI":"10.4049\/jimmunol.181.12.8595","article-title":"Mycobacterium tuberculosis-Specific CD8+ T Cells Require Perforin to Kill Target Cells and Provide Protection In Vivo","volume":"181","author":"Woodworth","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0076","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-3083.2011.02629.x","article-title":"Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 Fusion Protein, but Not an Adenovirus-Based Vaccine, Protects Mice Against Intravenous Challenge with Mycobacterium tuberculosis","volume":"75","author":"You","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejps.2024.106995_bib0077","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBo Mol. Med."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724003087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724003087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T15:20:58Z","timestamp":1736608858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724003087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":78,"alternative-id":["S0928098724003087"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106995","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradermal versus subcutaneous immunization: Effects of administration route using a lipid-PLGA hybrid nanoparticle tuberculosis vaccine","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106995"}}